Review compares clot-busting drugs for stroke patients
· UPIAn off-label clot-busting drug appears to work slightly better in treating stroke patients than an approved medication, a new review finds.
The clot-buster tenecteplase is associated with a slightly higher likelihood of excellent recovery and reduced disability three months following a stroke, compared to the drug alteplase, researchers report.
Advertisement